Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Real-World Clinical Outcomes of Concurrent Chemotherapy and Dose-Escalated Twice-Daily Radiotherapy With Simultaneous Integrated Boost (SIB) for Limited-Stage Small Cell Lung Cancer.

Clinical lung cancer·2026
Same author

Mn-Doped Nickel Telluride Dirac Semimetals with Engineered Dirac Cones for Accelerated Energy Conversion: Synergistic Electron Transfer and Adsorption Optimization.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Type-II Weyl Semimetal Mo-Doped WTe<sub>2</sub>: Urea Colloid Reduction Synthesis and Theoretical Confirmation of Topological Surface States for Energy Conversion Applications.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

Carvedilol vs. Metoprolol Effectiveness in Patients With Left Ventricular Assist Devices: A TriNetX Analysis.

Cureus·2025
Same author

Mediastinal Lipoma: An Unusual Cause of Progressive Dyspnea.

JACC. Case reports·2025
Same author

Mortality and Readmission Outcomes for Intensive and Conventional Cardiac Rehabilitation (MR-OFICR) Study.

Journal of community hospital internal medicine perspectives·2025

相关实验视频

Updated: Jun 27, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
06:29

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques

Published on: June 11, 2019

10.3K

扩散型大B细胞淋巴瘤呈现为心脏质量

Abdullah Nasir1, Yash B Patel1

  • 1Internal Medicine, Trinity Health Ann Arbor Hospital, Ann Arbor, USA.

Cureus
|June 6, 2024
PubMed
概括

心脏淋巴瘤是一种罕见的扩散性大B细胞淋巴瘤 (DLBCL) 的初始表现,可以影响右心室. 在这种情况下,早期诊断和R-mini-CHOP化疗导致了完全的代谢反应.

科学领域:

  • 心脏病学 心脏病学
  • 在瘤学瘤学.
  • 病理学 病理学 病理学

背景情况:

  • 作为淋巴瘤的初始表现,心脏参与是不常见的.
  • 扩散性大B细胞淋巴瘤 (DLBCL) 是最常见的心脏淋巴瘤类型,通常涉及右心房.
  • 心脏淋巴瘤可以从中枢DLBCL侵入心脏或作为原发性心脏淋巴瘤产生的.

研究的目的:

  • 报告一种罕见的心脏淋巴瘤病例,最初呈现出呼吸障碍.
  • 突出右心房淋巴瘤的诊断和治疗方法.
  • 强调在心脏质量的差异诊断中考虑淋巴瘤的重要性.

主要方法:

  • 一个84岁女性呼吸障碍病例研究.
  • 诊断成像包括计算机断层扫描血管造影 (CTA),胸前心声图 (TTE) 和正子发射断层扫描 (PET) 扫描.
  • Pleural 液体细胞学和光 in situ 杂交 (FISH) 进行了诊断; 用R-mini-CHOP进行化疗.

主要成果:

  • 图像检测显示右心房质量压缩心脏结构和中质量.
  • 胸腔液细胞学证实扩散型大B细胞淋巴瘤 (DLBCL) 具有特定的免疫表型和BCL2/18q异常.
  • 在三轮R-mini-CHOP化疗后,PET扫描显示了完全的代谢反应.
关键词:
心脏质量心脏质量化学疗法 化疗 化疗扩散的大B细胞淋巴瘤淋巴瘤淋巴瘤是什么右心房质量右心房质量

更多相关视频

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.9K
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.5K

相关实验视频

Last Updated: Jun 27, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
06:29

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques

Published on: June 11, 2019

10.3K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.9K
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.5K

结论:

  • 淋巴瘤应纳入右心房质量的差异诊断.
  • 胸外回声心电图 (TTE) 是一个关键的初始成像模式,但组织活检对于确定诊断至关重要.
  • 早期诊断和用标准化疗治疗DLBCL对于心脏淋巴瘤的良好结果至关重要.